To map the United States pharmaceutical supply chain and use data analytics to identify supply chain vulnerabilities and other national security threats.
About This Bill
Committee
Latest Action · July 18, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mapping America's Pharmaceutical Supply Act or the MAPS Act
This bill requires the Department of Health and Human Services (HHS) to support efforts to map the U.S. pharmaceutical supply chain and identify associated vulnerabilities.
As part of these efforts, HHS must support the development of a database of certain essential medicines and the identification of information about their supply chain, including the location of manufacturing facilities. Qualifying essential medicines are those that are likely to be needed in the event of a public health emergency or chemical, biological, radiological, or nuclear threat or for which a shortage would pose a significant threat to the U.S. health care system or at-risk populations.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.